Table 7.
Immunization
| Vaccine | Inactivated/Live, Attenuated | High dose steroids | Low dose steroids |
|---|---|---|---|
| Hepatitis B | I | YES | YES |
| Pertussis | I | YES | YES |
| Diphtheria | I | YES | YES |
| Tetanus | I | YES | YES |
| Polio (Salk) | I | YES | YES |
| H. Influenzae type B | I | YES | YES |
| Pneumococcal | I | YES | YES |
| Meningococcal | I | YES | YES |
| Flu | I | YES | YES |
| Human Papillomavirus | I | YES | YES |
| Varicella | LA | NOa,b | NOc |
| Measles | LA | NOa,b | NOc |
| Mumps | LA | NOa,b | NOc |
| Rubella | LA | NOa,b | NOc |
a Scottish Guidelines: feasible when high dose steroids (2 mg/kg/die for more than 7 days or 1,5 mg/kg/die for a month) have been discontinued for at least 3 months
b AAP: feasible one month after high-dose (≥2 mg /kg/die, or ≥20 mg/day if the child weighs more than 10 kg) corticosteroids discontinuation if the patient has been treated for more than 14 days, or immediately after the discontinuation if the patient has been treated for less than 14 days
c We recommend the use of live attenuated vaccines only after 3 months of corticosteroids discontinuation